nilla, Author at European Medical Journal - Page 6 of 20

My journey with diversity, equity and inclusion

Roche’s Davidek Herron offers his thoughts on the state of diversity, equity and inclusion in the pharma industry.

Mapping a path to personalised medicine

Despite continued advances in personalised medicine, there is still more to be done to encourage policy makers and payers to back these life-changing initiatives.

Pharma in the UK

In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.

Dr Zsuzsanna Devecseri

Access to oncology treatments, diversity and lessons in leadership

The GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and varied experience within the pharmaceutical industry.

Gaurav Sanganee

Beating budget cuts and quick wins for pharma marketers

In this episode, Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, discusses creating modular content and leveraging AI within the pharma industry.

Matt Lewis

AI, ChatGPT and modernising medical affairs

This week, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in pharma.

Claudia Martinez

Driving access to all medicines

This week, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation.

International Women's Day 2023 special

The GOLD team brings you a special International Women’s Day (IWD) podcast to celebrate the pursuit of gender parity.

Is medical affairs the Ferrari of the pharma industry?

In this episode, Isabel chats with Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS.

Breaking the bias in healthcare AI

The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?